Form 13-F position report

RITTER PHARMACEUTICALS INC

Reported by Trellus Management Company LLC

RTTR CUSIP 767836109 Manager CIK 0001307877

Reported 0 shares, down 17,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2017
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 8 Through Q1 2017

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for RITTER PHARMACEUTICALS INC held by Trellus Management Company LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

13 managers reported RITTER PHARMACEUTICALS INC for Q1 2017.

Managers reporting RITTER PHARMACEUTICALS INC in Q1 2017.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Knoll Capital Management LLC Reduced 802,434 -150,000 1.72% $1,139,000 3 qtrs
BAKER BROS ADVISORS LP Unchanged 400,000 0 < 0.01% $568,000 8 qtrs
Alyeska Investment Group L P Reduced 352,053 -300,232 < 0.01% $500,000 2 qtrs
VANGUARD GROUP INC Added 163,361 +38,372 < 0.01% $232,000 7 qtrs
BlackRock Inc New 60,059 +60,059 < 0.01% $85,000 1 qtr
Creative Planning Added 55,000 +18,000 < 0.01% $78,000 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Unchanged 29,614 0 < 0.01% $42,000 2 qtrs
ROYAL BANK OF CANADA New 12,000 +12,000 < 0.01% $17,000 1 qtr
WELLS FARGO & COMPANY MN Added 11,000 +6,000 < 0.01% $16,000 2 qtrs
UNITED CAPITAL FINANCIAL ADVISERS LLC New 10,000 +10,000 < 0.01% $14,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2017
Filed
May 01, 2017
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.